Posted on Thu, Jul 22, 2010 @ 10:07 AM
It can be difficult to transition a product from research to commercialization. It’s simply not feasible to conduct pilot testing in a fully GMP compliant setting because of the significant costs associated with meeting the FDA’s stringent regulations. To ensure consistency throughout the product lifecycle, IVD developers need to plan from the very beginning to choose component manufacturers who can match both the economic realities and changing regulatory requirements as a product matures.
Biosearch Technologies offers PilotDx™ oligos as a bridge between our custom oligos for research use and our GMP oligos for diagnostic assays. These oligos are ideal for design optimization and verification stages since they are produced using the same equipment, process, and personnel as our GMP oligos. PilotDx oligos have reduced cost and turnaround time compared to GMP oligos because of lower documentation overhead.
If you’re unsure which service is best for your product - custom oligos for research, PilotDx, or GMP oligos, you can request a free IVD consultation session at http://info.biosearchtech.com/IVDconsult/
Posted on Tue, Mar 09, 2010 @ 11:37 AM
Biosearch Technologies today announces that the company has expanded its licenses from Roche Molecular Systems, Inc. (Roche). The expanded license grants Biosearch the right to manufacture and sell validated kits to the in-vitro diagnostic (IVD) marketingplace as licensed products convered by multiple patents assigned to Roche.
To read the entire story, read the full press release.
Posted on Thu, Nov 19, 2009 @ 10:29 AM
Biosearch Technologies recently launched a video, Making of the Swine Flu Test Kit - Inside Biosearch Technologies, which had debuted last week at qPCR Symposium 2009 held in Millbrae, California. This video is an accurate re-enactment of Biosearch Technologies' rapid production of the H1N1 (Swine Flu) test kit that was developed by the Centers for Disease Control and Prevention (CDC).
Biosearch created this video because we wanted to show the world that a small company such as ourselves was able to contribute to battling against the worldwide outbreak of the swine flu. We were proud to be at the forefront of enabling genetic testing during a pandemic, a testing method that was not often used in past similar events.
Producing the video was a fun, collaborative project done internally at Biosearch. It gave us Biosearchers a chance to let our inner thespians shine. We first started with a small group of Biosearchers from various departments and teamed up to help draft a script. We cast the video with actual Biosearch employees, collected props, and staged all the necessary materials that we had used in April during the initial production of the swine flu test kits. With much preparation, we were able to film all the video content we needed in only a day and a half. The film was edited and finalized within a week. It was a nice break from our day-to day-tasks when we were filming ourselves at work and it made everyone feel appreciated for his or her hard work at Biosearch.
If you haven't seen the video already, you can view it at Biosearch's website: http://www.biosearchtech.com/support/videos/making-of-the-swine-flu-test-kit-inside-biosearch-technologies-video
Hope you enjoy it!
Posted on Wed, Nov 04, 2009 @ 09:47 AM
Biosearch Technologies announced today that the company has licensed from the CDC the novel H1N1 Influenza signatures along with the Influenza A sub-typing panel signatures. This licensing agreement with the CDC makes Biosearch Technologies the first oligo manufacturer to have the right to manufacture and sell dual-labeled probes and primers bearing the H1N1 and Influenza A sub-typing signatures.
To read the entire story, read the full press release.
Posted on Wed, Oct 28, 2009 @ 03:16 PM
Micronics, Inc., a leading developer of point-of-care molecular diagnostic products, announced today that it has entered into a license agreement with Biosearch Technologies, Inc. for the right to make, have made, use and sell Micronics' products that incorporate Biosearch's proprietary fluorophores and quencher dyes for nucleic acid assays. Under the terms of the worldwide license, Biosearch has granted Micronics a royalty-free use of certain of its chemistries for inclusion in Micronics' infectious disease tests for sale in underdeveloped countries.
To read the entire story, read the full press release.
Posted on Thu, Oct 01, 2009 @ 09:08 AM
Biosearch Technologies has ground breaking news to announce today. We licensed a family of patents covering practice of the 5' Nuclease process from Roche Molecular Systems (Roche). The Roche license provides freedom to operate, with respect to the Roche IP estate, for qPCR processes in the Diagnostic Research Field. This license makes Biosearch the first commercial oligonucleotide manufacturer to take the Roche license, which gives Biosearch the right to manufacture and sell dual-labeled probes for use in 5' Nuclease assays for internal research in the diagnostics field.
Click here to read the actual press release regarding Biosearch's licensing agreement with Roche Molecular Systems.
To learn about our services for the Molecular Diagnostics industry, visit our webpage, OUTSOURCE: Oligos for Molecular Diagnostics.